Lenvatinib in Advanced, Radioactive Iodine Refractory ...

Lenvatinib in Advanced, Radioactive Iodine– Refractory, Differentiated Thyroid Carcinoma Kay T.Yeung1 and Ezra E.W. Cohen2 Abstract Management options are limited for patients with radioactive iodine refractory, locally advanced, or metastatic differentiated thyroid carcinoma. Prior to 2015, sorafenib, a multitargeted ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download